Bruno Carlos
Sangro Gómez-Acebo
Catedrático de Universidad
![Foto de Bruno Carlos](/img/uploaded/6B445665F8CF9B93F87A62EA31963C07.png)
![Foto de Seoul National University Hospital](/img/noimage_org.png)
Seoul National University Hospital
Seúl, Corea del SurPublicaciones en colaboración con investigadores/as de Seoul National University Hospital (2)
2021
-
Safety, Efficacy, and Pharmacodynamics of Tremelimumab Plus Durvalumab for Patients With Unresectable Hepatocellular Carcinoma: Randomized Expansion of a Phase I/II Study
Journal of Clinical Oncology, Vol. 39, Núm. 27, pp. 2991-3001
2017
-
Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
The Lancet, Vol. 389, Núm. 10088, pp. 2492-2502